RU2009128399A - METHOD FOR TREATING ACUTE MYOCARDIAL INFARCTION COMPLICATED BY HEART FAILURE IN PATIENTS IN CRITICAL CONDITION ON THE BASIS OF APPLICATION OF NANOBIOPHARMATION MEANS (PERFERTORAN) - Google Patents
METHOD FOR TREATING ACUTE MYOCARDIAL INFARCTION COMPLICATED BY HEART FAILURE IN PATIENTS IN CRITICAL CONDITION ON THE BASIS OF APPLICATION OF NANOBIOPHARMATION MEANS (PERFERTORAN) Download PDFInfo
- Publication number
- RU2009128399A RU2009128399A RU2009128399/15A RU2009128399A RU2009128399A RU 2009128399 A RU2009128399 A RU 2009128399A RU 2009128399/15 A RU2009128399/15 A RU 2009128399/15A RU 2009128399 A RU2009128399 A RU 2009128399A RU 2009128399 A RU2009128399 A RU 2009128399A
- Authority
- RU
- Russia
- Prior art keywords
- heart failure
- myocardial infarction
- acute myocardial
- perfertoran
- nanobiopharmation
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Способ лечения острого инфаркта миокарда, осложненного сердечной недостаточностью, у больных в критическом состоянии на основе применения средств нанобиофармации, отличающийся тем, что больному вводят перфторан в дозе 5-7 мл/кг массы тела со скоростью 10-20 капель в минуту дважды в течение 48 ч. A method for the treatment of acute myocardial infarction complicated by heart failure in critically ill patients based on the use of nanobiopharmacy agents, characterized in that the patient is administered perftoran in a dose of 5-7 ml / kg body weight at a rate of 10-20 drops per minute twice for 48 h
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2009128399/15A RU2009128399A (en) | 2009-07-22 | 2009-07-22 | METHOD FOR TREATING ACUTE MYOCARDIAL INFARCTION COMPLICATED BY HEART FAILURE IN PATIENTS IN CRITICAL CONDITION ON THE BASIS OF APPLICATION OF NANOBIOPHARMATION MEANS (PERFERTORAN) |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2009128399/15A RU2009128399A (en) | 2009-07-22 | 2009-07-22 | METHOD FOR TREATING ACUTE MYOCARDIAL INFARCTION COMPLICATED BY HEART FAILURE IN PATIENTS IN CRITICAL CONDITION ON THE BASIS OF APPLICATION OF NANOBIOPHARMATION MEANS (PERFERTORAN) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2009128399A true RU2009128399A (en) | 2011-01-27 |
Family
ID=46308150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2009128399/15A RU2009128399A (en) | 2009-07-22 | 2009-07-22 | METHOD FOR TREATING ACUTE MYOCARDIAL INFARCTION COMPLICATED BY HEART FAILURE IN PATIENTS IN CRITICAL CONDITION ON THE BASIS OF APPLICATION OF NANOBIOPHARMATION MEANS (PERFERTORAN) |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2009128399A (en) |
-
2009
- 2009-07-22 RU RU2009128399/15A patent/RU2009128399A/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022015499A (en) | Methods of treating crohn's disease and ulcerative colitis. | |
| WO2010056302A3 (en) | Iontophoretic therapeutic agent delivery system | |
| UA99953C2 (en) | Treatment of dyspnea associated with acute heart failure | |
| NZ603319A (en) | Diabetes therapy | |
| MX2023005455A (en) | Methods of treating heart failure by administering omecamtiv mecarbil. | |
| EA201690069A1 (en) | THE USE OF HIGH DOSE PRIDOPIDINE FOR THE TREATMENT OF THE HANTINGTON'S DISEASE | |
| AR070842A1 (en) | DOSAGE REGIME FOR A S1P1 SELECTIVE RECEIVER AGONIST | |
| TW200634026A (en) | Antiangiogenesis therapy of autoimmune disease in patients who have failed prior therapy | |
| AR089862A1 (en) | USE OF LAQUINIMOD FOR THE TREATMENT OF PATIENTS WITH CROHN'S DISEASE IN THOSE WHO FAILS AN ANTI-FACTOR THUMOR NECROSIS THERAPY a (ANTI-TNFa) FIRST LINE | |
| MX2014002171A (en) | Combination treatments for hepatitis c. | |
| EA201492010A1 (en) | APPLICATION OF HIGH DOSE OF LACHINIMODE FOR TREATMENT OF MULTIPLE SCLEROSIS | |
| MX2013002244A (en) | Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2. | |
| WO2007087241A3 (en) | Treatment of ischemic disease using thrombopoietin | |
| WO2012063134A3 (en) | Cardiac glycoside analogs in combination with emodin for cancer therapy | |
| ATE543492T1 (en) | TREATMENT OF LUNG CANCER | |
| BR112017006272A2 (en) | The medicine constituent for medical treatment of chronic ulcerative colitis | |
| RU2009122281A (en) | MEANS FOR TREATMENT OF DISEASES IN VETERINARIUM ON THE BASIS OF PHOSPHONY SALT | |
| UA100883C2 (en) | Use of dronedarone or one of its pharmaceutically acceptable salts for preparing a medicament for the treatment of patients with arrhythmia and an increased creatinine level due to dronedarone administration | |
| EA202090558A1 (en) | SCHEMES OF TREATMENT | |
| RU2009128399A (en) | METHOD FOR TREATING ACUTE MYOCARDIAL INFARCTION COMPLICATED BY HEART FAILURE IN PATIENTS IN CRITICAL CONDITION ON THE BASIS OF APPLICATION OF NANOBIOPHARMATION MEANS (PERFERTORAN) | |
| NZ702666A (en) | A method of weight reduction | |
| EA201200466A1 (en) | THERAPEUTIC GAS FOR THE TREATMENT OF MITOCHONDRIAL DISORDERS | |
| EA201000739A1 (en) | NEW MEDICAL APPLICATION OF SALTS 3- (2,2,2-TRIMETHYL HYDRAZINIUM) PROPIONATE | |
| RU2007125208A (en) | METHOD FOR REDUCING BIOLOGICAL AGE (REJUVENATION OF THE ORGANISM) | |
| MX2021007324A (en) | Oral therapy using 6,8-bis-benzylthio-octanoic acid. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20110530 |